February 12, 2014
As you’re reading about saving your baby’s umbilical cord blood and tissue and learning more about CariCord, you may be wondering why you should deposit your baby’s cells in a cord blood bank in the first place?
Stem cells from umbilical cord blood and tissue have been used for more than 20 years in the treatment of more than 80 diseases, such as lymphoma, leukemia, various cancers, and countless other disorders. These treatments are FDA approved, and typically have a good success rate. Due to advances in research within the field of regenerative medicine, these numbers will only continue to grow in the coming years. All across the world, stem cell researchers and scientists have been seeking to create and develop therapies that will rebuild or replace damaged cells with stem cells and/or tissues that are grown from stem cells. This is how the aforementioned diseases can be cured.
It should be noted that clinical trials in the field of regenerative medicine that involved humans have been and are currently nearly exclusively conducted using the person’s own stem cells. These stem cells can be harvested from umbilical cord blood, cord tissue, or peripheral blood. As you may know, cord blood and tissue can only be harvested within a short window of time at the birth of a child, and thereafter stored in a cord blood bank until it is needed to infuse in the patient’s body, such as in the clinical trials.
Umbilical cord blood and tissue that is harvested at birth is preferred, as it has not been exposed to damage from radiation, toxins, environmental stress, and other facts, which is a possibility when using peripheral blood stem cells, which can be harvested from adult stem cells after birth. In order to achieve the highest quality of stem cells and thus have a better success rate in the treatment of a disease at some point down the road, it is necessary to harvest cord blood and stem cells at the time of birth.
As you can see, the process of private cord blood banking is crucial and needed. CariCord is the first company in the world to offer cord blood and tissue banking in an FDA licensed laboratory to private consumers. This public-private venture of ClinImmune Labs at the University of Colorado School of Medicine in Metro Denver is positioned to change the face of cord blood banking in the United States.